Dr David Herrmann
Dr David Herrmann completed his Diploma and PhD studies in the field of Developmental Biology in Freiburg, Germany. Due to the strong similarities between embryonic development and cancerogenesis he became interested in joining Dr Paul Timpson’s research group to work on invasion and metastasis, moving to Sydney to join the Garvan Institute of Medical Research in 2012.
Awards
- 2016Young Garvan Finalist: https://www.youtube.com/watch?v=6DPuo5aphU0
- 2010Traveling grant from the CDB Riken Center - Japan to attend the meeting “Frontiers in Organogenesis” - Kobe
- 2009Member of the GRK1104 “From Cells to Organs: Molecular Mechanisms of Organogenesis”
- 2008Alumni-Diploma Award - University of Freiburg - Faculty of Biology
Selected publications
See all publications- 2024Science Advances10.1126/sciadv.adl1197
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.
- 2023BioRxiv : The Preprint Server for Biology10.1101/2023.12.03.569812
Fibroblast Growth Factor-induced lens fiber cell elongation is driven by the stepwise activity of Rho and Rac.
- 2023Science Advances10.1126/sciadv.abp9530
BCRP drives intrinsic chemoresistance in chemotherapy-naïve breast cancer brain metastasis.
- 2023Nature Cancer10.1038/s43018-023-00614-y
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.
- 2023Science Advances10.1126/sciadv.adf9063
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse.